Hunt Kelly J, Resendez Roy G, Williams Ken, Haffner Steve M, Stern Michael P
Department of Medicine, University of Texas Health Science Center at San Antonio, 78229-3900, USA.
Circulation. 2004 Sep 7;110(10):1251-7. doi: 10.1161/01.CIR.0000140762.04598.F9. Epub 2004 Aug 23.
To assess the utility of clinical definitions of the metabolic syndrome (MetS) to identify individuals with increased cardiovascular risk, we examined the relation between the MetS, using both the National Cholesterol Education Program (NCEP) and the World Health Organization definitions, and all-cause and cardiovascular mortality in San Antonio Heart Study participants enrolled between 1984 and 1988.
Among 2815 participants, 25 to 64 years of age at enrollment, 509 met both criteria, 197 met NCEP criteria only, and 199 met WHO criteria only. Over an average of 12.7 years, 229 deaths occurred (117 from cardiovascular disease). Moreover, in the primary prevention population of 2372 participants (ie, those without diabetes or cardiovascular disease at baseline), 132 deaths occurred (50 from cardiovascular disease). In the primary prevention population, the only significant association adjusted for age, gender, and ethnic group was between NCEP-MetS and cardiovascular mortality (hazard ratio [HR], 2.01; 95% CI, 1.13-3.57). In the general population, all-cause mortality HRs were 1.47 (95% CI, 1.13-1.92) for NCEP-MetS and 1.27 (95% CI, 0.97-1.66) for WHO-MetS. Furthermore, for cardiovascular mortality, there was evidence that gender modified the predictive ability of the MetS. For women and men, respectively, HRs for NCEP-MetS were 4.65 (95% CI, 2.35-9.21) and 1.82 (95% CI, 1.14-2.91), whereas HRs for WHO-MetS were 2.83 (95% CI, 1.55-5.17) and 1.15 (95% CI, 0.72-1.86).
In summary, although both definitions were predictive in the general population, the simpler NCEP definition tended to be more predictive in lower-risk subjects.
为评估代谢综合征(MetS)的临床定义用于识别心血管疾病风险增加个体的效用,我们研究了采用美国国家胆固醇教育计划(NCEP)和世界卫生组织(WHO)定义的MetS与1984年至1988年纳入圣安东尼奥心脏研究的参与者的全因死亡率和心血管疾病死亡率之间的关系。
在2815名入组时年龄为25至64岁的参与者中,509人符合两种标准,197人仅符合NCEP标准,199人仅符合WHO标准。平均随访12.7年期间,发生了229例死亡(117例死于心血管疾病)。此外,在2372名参与者的一级预防人群中(即基线时无糖尿病或心血管疾病者),发生了132例死亡(50例死于心血管疾病)。在一级预防人群中,经年龄、性别和种族校正后,唯一显著的关联是NCEP定义的MetS与心血管疾病死亡率之间的关联(风险比[HR]为2.01;95%置信区间[CI]为1.13 - 3.57)。在总体人群中,NCEP定义的MetS的全因死亡率HR为1.47(95%CI为1.13 - 1.92),WHO定义的MetS的全因死亡率HR为1.27(95%CI为0.97 - 1.66)。此外,对于心血管疾病死亡率,有证据表明性别改变了MetS的预测能力。对于女性和男性,NCEP定义的MetS的HR分别为4.65(95%CI为2.35 - 9.21)和1.82(95%CI为1.14 - 2.91),而WHO定义的MetS的HR分别为2.83(95%CI为1.55 - 5.17)和1.15(95%CI为0.72 - 1.86)。
总之,虽然两种定义在总体人群中都具有预测性,但更简单的NCEP定义在低风险受试者中往往更具预测性。